Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ascorbyl palmitate is a **lipophilic ester of ascorbic acid (vitamin C) and palmitic acid**, resulting in a fat-soluble form of vitamin C with **antioxidant**, **antiproliferative**, and **antineoplastic** activities[2][6][7][4][3]. It protects cellular components and oil-based formulations from oxidative damage by scavenging free radicals[3][4]. Ascorbyl palmitate can exert cytotoxic effects in cancer cell models, may alter DNA synthesis, inhibit ornithine decarboxylase induction, and has shown activity in animal models reducing tumor formation[1][2][4][7]. Its amphipathic nature enables its inclusion in **pharmaceutical, food, and cosmetic formulations** as an antioxidant and preservative, and in topical products for potential skin-brightening and anti-aging effects[3][7]. Ascorbyl palmitate is considered to have vitamin C activity, but its oral supplementation is less effective than water-soluble ascorbic acid due to intestinal breakdown[6]. It is manufactured synthetically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ascorbyl palmitate.